In early June, Covidien reached an agreement to acquire Midwest-based endovascular company ev3, Inc. ev3 manufactures angioplasty balloons, stents, and other supplies used to treat vascular diseases.
The acquisition of ev3 will allow Covidien to become a larger player in the medical equipment field, and will significantly expand its presence in the vascular device market.
Click here to read more in the ev3 company announcement.
No comments:
Post a Comment